BEX2 and neoplasm: Regarding the mechanism of the tumor-promoting role of BEX2, we showed that BEX2 promoted tumor growth and inhibited doxorubicin-induced apoptosis in vivo, which was reversed by inhibiting mitophagy with liensinine.